Literature DB >> 10365690

Interaction of hyperthermia with Taxol in human MCF-7 breast adenocarcinoma cells.

B Z Leal1, M L Meltz, N Mohan, J Kuhn, T J Prihoda, T S Herman.   

Abstract

Hyperthermia treatments (43 degrees C, 1 h) were performed on exponentially growing MCF-7 breast adenocarcinoma cells at the beginning, middle, or end of 24 h incubations of the cells in vitro with Taxol (paclitaxel). When the cells were heated at the beginning or middle of the Taxol incubation, the hyperthermia treatment protected against the toxic effect of each of the Taxol concentrations examined (5, 10 and 100 nM). Consistent with earlier studies, Taxol treatment at 37 degrees C resulted in an accumulation of greater than 94% of the cells in G2/M at 24 h. Heating the cells at the middle or end of the Taxol treatment resulted in a similar accumulation. However, heat treatment during the first hour of Taxol exposure resulted in a significantly smaller percentage of cells (approximately 50%) in G2/M. HPLC analysis showed that at 37 degrees C, Taxol uptake into MCF-7 cells approached maximum within 0.25 h and increased only slightly more over the next 11.75 h. The parental Taxol level was markedly lower by 24 h. In contrast, 1 h hyperthermia treatments at the beginning or middle of the Taxol incubation resulted in higher Taxol concentrations at 12 and 24h, and higher intracellular concentrations overall than at 37 degrees C. These results indicate that hyperthermia inhibits Taxol related cell cycle effects and cytotoxicity, in spite of causing higher concentrations of Taxol to be present in heated cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365690     DOI: 10.1080/026567399285747

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  4 in total

1.  Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer.

Authors:  Chelsea D Landon; Ji-Young Park; David Needham; Mark W Dewhirst
Journal:  Open Nanomed J       Date:  2011-01-01

Review 2.  Stressing mitosis to death.

Authors:  Andrew Burgess; Mina Rasouli; Samuel Rogers
Journal:  Front Oncol       Date:  2014-06-04       Impact factor: 6.244

3.  Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial.

Authors:  Kidong Kim; Jae-Hoon Kim; Seung Cheol Kim; Yong Beom Kim; Byung-Ho Nam; Jae Hong No; Hanbyoul Cho; Woong Ju; Dong Hoon Suh; Yun Hwan Kim
Journal:  Exp Ther Med       Date:  2021-05-21       Impact factor: 2.447

4.  Quantifying cell death induced by doxorubicin, hyperthermia or HIFU ablation with flow cytometry.

Authors:  Paul Christopher Lyon; Visa Suomi; Philip Jakeman; Leticia Campo; Constantin Coussios; Robert Carlisle
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.